HisgAtlas 1.0: a human immunosuppression gene database

Abstract Immunosuppression is body’s state in which the activation or efficacy of immune system is weakened. It is associated with a wide spectrum of human diseases. In the last two decades, tremendous efforts have been made to elucidate the mechanism of hundreds of immunosuppression genes. Immunosuppression genes could be valuable drug targets or biomarkers for the immunotherapeutic treatment of different diseases. However, the information of all previously identified immunosuppression genes is dispersed in thousands of publications. Here, we provide the HisgAtlas database that collects 995 previously identified human immunosuppression genes using text mining and manual curation. We believe HisgAtlas will be a valuable resource to search human immunosuppression genes as well as to investigate their functions in further research. Database URL: http://biokb.ncpsb.org/HisgAtlas/

[1]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[2]  Gang Fu,et al.  Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data , 2014, Nucleic Acids Res..

[3]  Shohei Koyama,et al.  Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints , 2016, Nature Communications.

[4]  Anushya Muruganujan,et al.  PANTHER version 10: expanded protein families and functions, and analysis tools , 2015, Nucleic Acids Res..

[5]  L. Chatenoud,et al.  Teaching the immune system “self” respect and tolerance , 2014, Science.

[6]  Axel Hoos,et al.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies , 2016, Nature Reviews Drug Discovery.

[7]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[8]  Jeyakumar Natarajan,et al.  Overview of the interactive task in BioCreative V , 2015, Database J. Biol. Databases Curation.

[9]  F. Salaffi,et al.  Immunogenicity and autoimmunity during anti-TNF therapy. , 2013, Autoimmunity reviews.

[10]  N A Mitchison,et al.  Immune suppression genes. , 1989, Clinical and experimental immunology.

[11]  Rachael P. Huntley,et al.  The GOA database in 2009—an integrated Gene Ontology Annotation resource , 2008, Nucleic Acids Res..

[12]  I. Xenarios,et al.  UniProtKB/Swiss-Prot, the Manually Annotated Section of the UniProt KnowledgeBase: How to Use the Entry View. , 2016, Methods in molecular biology.

[13]  A. Thomson,et al.  Tolerogenic dendritic cells and the quest for transplant tolerance , 2007, Nature Reviews Immunology.

[14]  Or Gozani,et al.  Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity , 2008, Proceedings of the National Academy of Sciences.

[15]  V. Boussiotis,et al.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A , 2012, Cell cycle.

[16]  Jian Zhang,et al.  Protein Ontology: a controlled structured network of protein entities , 2013, Nucleic Acids Res..

[17]  M. Dougados,et al.  Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. , 2005, The New England journal of medicine.

[18]  José Luís Oliveira,et al.  BeCAS: biomedical concept recognition services and visualization , 2013, Bioinform..

[19]  Sarah C. Ayling,et al.  The Ensembl gene annotation system , 2016, Database J. Biol. Databases Curation.

[20]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[21]  Shu-Hsia Chen,et al.  Advancements in immune tolerance. , 2008, Advanced drug delivery reviews.